Back to NVAX Stock Lookup

Novavax (NVAX) – PRNewswire

Jul 6, 2021 08:30 AM Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021
Jun 30, 2021 05:26 PM Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine
Jun 17, 2021 04:02 PM Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum
Jun 17, 2021 09:22 AM Novavax to Participate in National Vaccine Advisory Committee Meeting
Jun 14, 2021 04:05 PM Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously
Jun 14, 2021 06:00 AM Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
Jun 11, 2021 04:05 PM Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine
Jun 9, 2021 09:03 AM Novavax to Host Maryland Governor Larry Hogan at Site of Future Novavax Vaccines Innovation Campus and Global Headquarters
Jun 7, 2021 04:05 PM Novavax to Participate in Panel at BIO Digital 2021
May 27, 2021 08:30 AM Novavax to Participate in Jefferies Virtual Healthcare Conference
May 24, 2021 05:03 PM Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update
May 22, 2021 12:20 PM Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea
May 21, 2021 08:53 AM Novavax Honored by Maryland Tech Council During 2021 Industry Awards Celebration
May 10, 2021 04:02 PM Novavax Reports First Quarter 2021 Financial Results and Operational Highlights
May 10, 2021 09:12 AM Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate
May 6, 2021 09:05 AM Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility
May 5, 2021 05:03 PM New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
May 3, 2021 08:51 AM Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine
Apr 23, 2021 04:02 PM Novavax to Host Conference Call to Discuss First Quarter Financial Results and Operational Highlights on May 10, 2021
Apr 23, 2021 05:00 AM Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
Apr 14, 2021 05:39 PM Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
Apr 13, 2021 05:34 PM Novavax Announces Leadership Updates
Apr 5, 2021 04:05 PM Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover
Apr 5, 2021 08:50 AM Novavax CEO Stan Erck to Participate in Longwood Healthcare Leaders Meeting
Mar 29, 2021 04:02 PM GSK to support manufacture of Novavax' COVID-19 vaccine
Mar 11, 2021 04:02 PM Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials
Sep 25, 2020 07:00 AM Endo Announces Fill-Finish Manufacturing and Services Agreement for Novavax COVID-19 Vaccine Candidate
Aug 10, 2020 04:05 PM AGC Biologics Expands Partnership with Novavax
Jul 23, 2020 04:04 PM Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
Jun 3, 2020 07:00 AM Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine
Apr 16, 2020 02:59 AM Novavax to commence COVID-19 vaccine trial with Nucleus Network

Back to NVAX Stock Lookup